Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients
Condition(s):Breast CancerLast Updated:October 24, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Breast CancerLast Updated:October 24, 2022Completed
Condition(s):Short Bowel SyndromeLast Updated:March 22, 2024Not yet recruiting
Condition(s):DiarrheaLast Updated:December 15, 2022Terminated
Condition(s):HIV Enteropathy; Diarrhea With HIVLast Updated:August 31, 2020Completed
Condition(s):Acquired Immunodeficiency Syndrome; Healthy Volunteers; HIV/AIDS; HIV Diarrhea; Human Immunodeficiency VirusLast Updated:October 22, 2021Completed
Condition(s):Chronic Diarrhea of Unknown OriginLast Updated:May 17, 2023Recruiting
Condition(s):HIV Associated DiarrheaLast Updated:September 3, 2020Completed
Condition(s):Irritable Bowel Syndrome; Colonic Diseases; Diarrhea; Gastrointestinal DiseaseLast Updated:November 25, 2019Completed
Condition(s):Cancer Therapy-Related Diarrhea; Chemotherapy-related Diarrhea; Adult Solid Tumor; Prophylaxis of Diarrhea; Symptomatic Relief of Diarrhea; Targeted Therapy-related DiarrheaLast Updated:March 22, 2024Active, not recruiting
Condition(s):Irritable Bowel SyndromeLast Updated:November 25, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.